Safety and Efficacy Study of Recombinant Human Insulin-Like Growth Factor-I/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 (rhIGF-I/rhIGFBP-3) In Myotonic Dystrophy Type 1

Clinical trial NCT00577577 · COMPLETED

Trial details

NCT number: NCT00577577
Sponsor: Insmed Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myotonic Dystrophy Type 1

Start date: 2007-12-01
Primary completion: 2008-12-29
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.